Quantcast

Latest Bacterial diseases Stories

2014-02-20 23:26:56

New research focuses on skin bacteria as a major factor in the rapid spread of MRSA. Grime Busters explains how a collegiate hockey venue is having success in battling the germs associated with the disease through the use of a bacteria-killing product. Gaylord, MI (PRWEB) February 20, 2014 The latest research on the MRSA skin disease, published by the American Society for Microbiology, holds important information for everyone who is trying to kill the germs that spread bacteria-related...

2014-02-19 12:28:05

LUND, Sweden, Feb. 19, 2014 /PRNewswire/ -- BONESUPPORT, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic surgery, announced today the launch of a new registry to collect long term data of CERAMENT(TM)|G, the first injectable antibiotic eluting, osteoconductive, ceramic bone substitute indicated to promote and protect bone healing being jeopardized by infection. The registry is part of the company's...

2014-02-19 08:31:18

SAN DIEGO, Feb. 19, 2014 /PRNewswire/ -- CURx Pharmaceuticals today announced it has entered into a global license agreement with Gilead Sciences, Inc. for development of Fosfomycin:Tobramycin for Inhalation (FTI) to treat Pseudomonas aeruginosa lung infection in cystic fibrosis (CF) patients. FTI is ready for Phase III clinical trials, having successfully completed a Phase II trial in CF patients. (Logo: http://photos.prnewswire.com/prnh/20140212/MM64137LOGO) "This is a great...

2014-02-12 12:30:23

Candidate Oral Bait Vaccine Targets the Vector, Not Humans, to Interrupt Cycle of Transmission MEMPHIS, Tenn., Feb. 12, 2014 /PRNewswire/ -- A new technology has been shown to reduce the level of tick infection of Borrelia burgdorferi, the cause of Lyme disease. Study details were published online today in the Journal of Infectious Diseases, in advance of print publication. The oral bait vaccine was distributed to white-footed mice, which account for the majority of the transmission...

2014-02-11 08:33:36

LAUSANNE, Switzerland, February 11, 2014 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs as well as companion diagnostics, and Affinium Pharmaceuticals (Affinium), a Canadian company focusing on the development of a platform of novel, targeted narrow-spectrum antibacterial therapeutics, today announced the acquisition by Debiopharm of Affinium's clinical and...

2014-02-10 23:02:12

Westwood California Doctor, Murray Susser MD announces a new approach for both diagnosing and treating Chronic Fatigue Syndrome. (PRWEB) February 10, 2014 Dr. Murray Susser MD announces a new approach to Chronic Fatigue Syndrome in Westwood, California, Dr. Susser is announcing his expanded approach to help people who suffer from Chronic Fatigue Syndrome. This approach includes both diagnoses and treatment of Chronic Fatigue Syndrom. Dr. Murry Susser co-authored the book, “Solving the...

2014-02-09 04:20:17

LONDON, February 9, 2014 /PRNewswire/ -- INTERNATIONAL photographer and artist Anne Geddes invites us to take a fresh look at disability, with three new thought-provoking portraits of UK children who have lost limbs to meningitis. (Photo: http://photos.prnewswire.com/prnh/20140209/668113-a ) (Photo: http://photos.prnewswire.com/prnh/20140209/668113-b ) (Photo: http://photos.prnewswire.com/prnh/20140209/668113-c ) Amber Travers (5),...

2014-02-07 13:09:09

Production of an exceptionally large surface protein prevents bacteria from forming clumps and reduces their ability to cause disease A genetic mechanism that controls the production of a large spike-like protein on the surface of Staphylococcus aureus (staph) bacteria alters the ability of the bacteria to form clumps and to cause disease, according to a new University of Iowa study. The new study is the first to link this genetic mechanism to the production of the giant surface protein...

2014-02-06 16:27:13

Tens of Thousands Die Annually from Vaccine-preventable Diseases WASHINGTON, Feb. 6, 2014 /PRNewswire-USNewswire/ -- Today, the U.S. Centers for Disease Control and Prevention (CDC) released new adult immunization rates for six vaccines recommended for American adults, finding rates fall far below national goals. While some rates improved slightly from 2011 to 2012, rates continued to be as low as: (Logo: http://photos.prnewswire.com/prnh/20100204/TFAHLOGO) -- Only 14 percent of...

2014-02-04 23:26:11

Grime Busters and Amazing! NOK OUT™ is on a mission to educate consumers and eradicate disease-causing organisms. At 2,000 PPM, NOK OUT™ is a serious contender in the battle against these threatening adversaries. Gaylord, MI (PRWEB) February 04, 2014 The most resistant organism in the healthcare environment is the bacterial spore. Bacterial spores serve largely as a resting, or dormant, stage in the bacterial life cycle, serving to reserve the bacterium through periods of unfavorable...


Latest Bacterial diseases Reference Libraries

0_cef863082995e6cb66fa4a692bf165a7
2011-04-28 16:37:36

Vibrio vulnificus is a species of Gram-negative, motile, curved, rod-shaped bacteria of the Vibrio Genus. Hollis et al. first reported it in 1976. It was given the name Beneckea vulnifica by Reichelt et al. in 1976 and in 1979 Vibrio vulnificus by Farmer. V. vulnificus is related to V. cholerae and is present in marine environments such as estuaries, brackish ponds, or coastal areas. It causes an infection often incurred after eating seafood, especially raw or undercooked oysters. It can...

72_f634c1b2916580c60814457a175ea810
2011-04-28 15:06:23

Vibrio cholerae is a gram negative comma-shaped bacterium with a polar flagellum that causes cholera in humans. V. cholerae belongs to the gamma subdivision of the Proteobacteria. Classical and El Tor are the two types of V. Cholerae identified by hemaggluttination testing. El Tor is found throughout the world, while the classical biotype is found only in Bangladesh. It was first isolated as the cause of cholera by Italian anatomist Filippo Pacini in 1854; however, this discovery was not...

0_1b337eb3ae50456f130e22153cc80436
2011-04-28 14:40:22

Streptococcus pyogenes is a spherical, Gram-positive bacterium is the cause of Group A streptococcal infections. It displays streptococcal group A antigen on its cell wall. When it is cultured on blood agar plates it produces large zones of beta-hemolysis. They are catalase-negative and in ideal conditions it has an incubation period of about 1-3 days. It is an infrequent part of the skin flora. It is the cause of many important human diseases, ranging from mild superficial skin infections...

72_eee8f4e550996ac6ae01af15eddb314c
2011-04-26 20:20:41

Staphylococcus aureus is a facultative anaerobic gram-positive coccus, and is the most common cause of staph infections. It is commonly part of the skin flora found in the nose and on skin. Around 20% of the human population is long-term carriers. It gets its golden color due to its carotenoid pigment staphyloxanthin. The pigment acts as a virulence factor with an antioxidant action that allows the microbe to evade death by reactive oxygen species used by the host immune system. Staphylococci...

0_86d2284273d6244c9ff290b35cdd2cf2
2011-04-25 21:24:26

Rickettsia rickettsii is a gram-negative bacterium native to the New World and causes the malady known as Rocky Mountain spotted fever (RMSF). It is transmitted through the bit of an infected tick when it feeds on animals and humans. Humans are not necessary hosts in the rickettsia-tick life cycle but they can be. S. Burt Wolbach created the first detailed description of the etiologic agent in 1919. He recognized it as an intracellular bacterium seen most frequently in endothelial cells....

More Articles (19 articles) »
Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.